首页
订购/客服:400-666-5481

MS402

    
≥98%

3-Chloro-N-(4-methoxyphenyl)-4-((2-methyl-3-oxocyclopent-1-en-1-yl)amino)benzamide

源叶(MedMol)
S89073 一键复制产品信息
1672684-68-2
C20H19ClN2O3
370.833
MS402; MS-402; MS 402
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S89073-5mg
≥98%

¥150.00

6 - - - -
S89073-10mg
≥98%

¥280.00

7 - - - -
S89073-25mg
≥98%

¥520.00

6 - - - -
S89073-100mg
≥98%

¥1520.00

货期:2-3天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: MS402 is a BD1-selective BET BrD inhibitor with Kis of 77 nM, 718 nM, 110 nM, 200 nM, 83 nM, and 240 nM for BRD4(BD1), BRD4(BD2), BRD3(BD1), BRD3(BD2), BRD2(BD1) and BRD2(BD2), respectively. MS402 blocks Th17 cell differentiation and ameliorates colitis in mice
靶点: BRD4-BD1:77 nM (Ki);BRD2-BD1:83 nM (Ki);BRD3-BD1:110 nM (Ki);BRD3-BD2:200 nM (Ki);BRD2-BD2:240 nM (Ki);BRD4-BD2:718 nM (Ki);EpigeneticReaderDomain
体内研究: Reconstitution with naïve CD4+CD45RBhi cells isolated from spleen and lymph nodes of C57BL/6 mice, Rag1-/- mice begin losing weight after 4 week. MS402 (10 mg/kg; intraperitoneally twice a week for 3 weeks) shows much less weight loss. Animal Model: C57BL/6 mice, Rag1-/- mice with T-cell transfer-induced colitis model Dosage: 10 mg/kg Administration: Intraperitoneally twice a week for 3 weeks Result: Showed much less weight loss.
参考文献: 1. Cheung K, et al. BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice. Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):2952-2957.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.697 ml 13.483 ml 26.966 ml
5 mM 0.539 ml 2.697 ml 5.393 ml
10 mM 0.27 ml 1.348 ml 2.697 ml
50 mM 0.054 ml 0.27 ml 0.539 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×